US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Russia Central Nervous System Drugs Market Insights - 2015
3/14/2015 | published by: Fore Pharma
... in Russia. The research includes CNS drugs market size estimates for 2014 in Russia, market size forecast for six years to 2020, drugs sales estimates, market share, market analysis by therapeutic sub-groups, and competitor analysis. ...  |  read more...
USD 1,380
Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015
2/27/2015 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Subependymal Giant Cell Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Pilocytic Astrocytoma Global Clinical Trials Review, H1, 2015
2/27/2015 | published by: GlobalData
... information and data relating to the clinical trials on Pilocytic Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Nicotine Addiction - Pipeline Review, H1 2015
3/19/2015 | published by: Global Markets Direct
... therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015
3/19/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Traumatic Brain Injury Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... in traumatic brain injury partnering deals Top traumatic brain injury deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Traumatic Brain Injury Partnering 2010-2015 provides understanding and access ...  |  read more...
USD 795
Migraine Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Migraine Partnering 2010-2015 provides understanding and access to the migraine partnering deals and agreements entered into by the worlds ...  |  read more...
USD 795
Anxiety Disorders - Pipeline Review, H1 2015
2/10/2015 | published by: Global Markets Direct
... therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Central Nervous System Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and ...  |  read more...
USD 1,495
Alcohol Addiction Global Clinical Trials Review, H1, 2015
2/18/2015 | published by: GlobalData
... information and data relating to the clinical trials on Alcohol Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Anorexia Nervosa Global Clinical Trials Review, H1, 2015
2/18/2015 | published by: GlobalData
... information and data relating to the clinical trials on Anorexia Nervosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets
3/1/2015 | published by: BCC Research
... to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%. This report provides: An overview of the regional and global markets for Autism Spectrum Disorder (ASD) therapies and diagnostics. Analyses of global ...  |  read more...
USD 6,650
Dyslexia Global Clinical Trials Review, H1, 2015
2/27/2015 | published by: GlobalData
... relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Nicotine Addiction Global Clinical Trials Review, H1, 2015
2/27/2015 | published by: GlobalData
... information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015
2/18/2015 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Recurrent Malignant Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Brain Tumor. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Depression. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Depression. ...  |  read more...
USD 2,000
Global Migraine Drugs Market 2015-2019
2/4/2015 | published by: TechNavio - Infiniti Research Ltd.
... Given their hormonal fluctuation, women are more susceptible to have migraine than men. Anti-migraine drugs are the therapeutic agents to be used against migraine. Treatment includes painkillers, anti-inflammatory painkillers, anti-sickness medicines, and triptan medicines. TechNavio's ...  |  read more...
USD 3,000
Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Malignant Glioma. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Restless Legs Syndrome. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Anxiety Disorders. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Tension -Type Headache. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Autism. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Autism. ...  |  read more...
USD 2,000
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Brain Hemorrhage. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Brain Cancer Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... partnering deals Top brain cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Brain Cancer Partnering 2010-2015 provides understanding and access to the brain cancer partnering deals ...  |  read more...
USD 795
1  2    4    6  7  8  9  10